🇺🇸 FDA
Patent

US 8920848

Use of cellular extracts for skin rejuvenation

granted A61KA61K35/60A61K8/676

Quick answer

US patent 8920848 (Use of cellular extracts for skin rejuvenation) held by REGENICS AS expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENICS AS
Grant date
Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K35/60, A61K8/676, A61K8/982, A61K8/987